Physician profile
Daniel R Euler
NPI 1700294253
$5,481.19
in general payments reported to CMS, 2019-2025
36 companies · $1,893 in 2025
The $1,893 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $573 · 2023: $1,233 · 2024: $1,782 · 2025: $1,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,792 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,791.62 |
| Education | $117.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $645.54 | 2022-2025 | Farxiga, Brilinta |
| Edwards Lifesciences Corporation | $493.46 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $421.50 | 2023-2025 | |
| Pfizer INC. | $356.22 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $304.56 | 2022-2025 | Dupixent, Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $304.01 | 2023-2025 | Lifevest |
| Novo Nordisk INC | $263.22 | 2023-2025 | Wegovy, Ozempic |
| Endologix LLC | $184.18 | 2024 | Endocross Device, Torus Stent Graft System |
| Amgen INC. | $160.18 | 2022-2024 | Repatha |
| Inari Medical, INC. | $152.28 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $150.00 | 2022 | |
| Lundbeck LLC | $150.00 | 2025 | Rexulti |
| Silk Road Medical, INC. | $149.27 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $149.07 | 2022-2024 | Xarelto |
| Convatec INC. | $134.61 | 2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $130.07 | 2022-2024 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $128.32 | 2024 | Arcalyst |
| Bioxcel Therapeutics, INC. | $125.00 | 2023 | Igalmi |
| Lexicon Pharmaceuticals, INC. | $124.59 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $122.09 | 2023 | Gattex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.61 | 2022-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $106.06 | 2022-2025 | |
| Abbvie INC. | $102.56 | 2025 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $99.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $66.78 | 2023-2025 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $47.40 | 2024 | Opsumit, Uptravi |
| Bridgebio Pharma, INC. | $43.92 | 2025 | Attruby |
| Chiesi USA, INC. | $41.53 | 2023-2025 | Cleviprex, Kengreal |
| Medtronic, INC. | $38.13 | 2025 | V-Loc 180 |
| Scpharmaceuticals INC. | $35.41 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $30.75 | 2025 | Amvuttra |
| Integra Lifesciences Corporation | $24.15 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Atricure, INC. | $23.15 | 2025 | Synergy Ablation System |
| Abbott Laboratories | $22.59 | 2023 | Cardiomems |
| Kiniksa Pharmaceuticals, Ltd. | $19.72 | 2023 | Arcalyst |
| Altathera Pharmaceuticals LLC | $16.09 | 2023 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Euler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.